The Food and Drug Administration (FDA) has approved Romvimza ™ (vimseltinib) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will ...
News Medical on MSN5d
FDA Approves Vimseltinib for Tenosynovial Giant Cell Tumor (TGCT)The U.S. Food and Drug Administration has approved vimseltinib for adult patients with a rare condition called tenosynovial ...
The US Food and Drug Administration has approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC) to treat adult ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback